Musclepharm Corp: Wynnefield Partners Small Cap Value Lp I Bought Stake

January 3, 2018 - By Migdalia James

 Musclepharm Corp: Wynnefield Partners Small Cap Value Lp I Bought Stake

Investors sentiment Infinity in Q3 2017. Its in 2017Q2. It [12345], as 0 investors sold MusclePharm Corporation shares while 0 reduced holdings. 0 funds opened positions while 1 raised stakes. 3.29 million shares or 10.81% more from 2.97 million shares in 2017Q2 were reported.

Wynnefield Cap, a New York-based fund reported 1.64M shares. New York-based Howard Capital Management has invested 0% in MusclePharm Corporation (OTCMKTS:MSLP).

The New Wynnefield Partners Small Cap Value Lp I Holding in Musclepharm Corp

Wynnefield Partners Small Cap Value Lp I reported SC 13D/A form with the SEC for Musclepharm Corp. Access it here: 000114420418000522. As reported by Wynnefield Partners Small Cap Value Lp I, the filler owns 9.1% or 939,060 shares of the Consumer Staples–company.

Musclepharm Corp stake is new for [reportingPerson]. Date of activity: &Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;&Oline;. This shows Wynnefield Partners Small Cap Value Lp I’s positive view for Musclepharm Corp.

Business Profile

MusclePharm Corporation is a performance lifestyle company. The Company develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. The Company’s portfolio of brands targets various types of fitness enthusiasts, including professional, combat sport, weight training, bodybuilding, running, basketball, soccer, cross fit, golf, tennis, volleyball and other active lifestyle activities. The MusclePharm Sport Series includes supplements that cover the needs of athletes, including their workout needs. MusclePharm Hybrid Series products include Assault, Amino1 and Combat Protein Powder. FitMiss products are designed and formulated for the active woman’s lifestyle utilizing ingredients that cover the range of busy women’s needs, including weight loss, multi-vitamins, protein shakes, detox, skin care and pre-workout energy mixes. MusclePharm Core products include BCAA 3:1:2, CLA Core and Fish Oil.

SEC Form 13D.

The stock increased 6.15% or $0.04 during the last trading session, reaching $0.69. About 19,036 shares traded. MusclePharm Corporation (OTCMKTS:MSLP) has 0.00% since January 3, 2017 and is . It has underperformed by 16.70% the S&P500.

MusclePharm Corporation develops, manufactures, markets, and distributes nutritional supplements in the United States and internationally. The company has market cap of $10.11 million. It offers a range of powders, capsules, tablets, and gels. It has a 26.54 P/E ratio. The companyÂ’s MusclePharm Hybrid series products include Assault, Amino1, and Combat Protein Powder; and MusclePharm Core products comprise BCAA 3:1:2, CLA Core, and Fish Oil to meet the day-in and day-out demands of athletes.

More notable recent MusclePharm Corporation (OTCMKTS:MSLP) news were published by: which released: “MusclePharm up 19%, capital raise in the offing?” on September 21, 2017, also with their article: “Muscle Pharm – 50% Revenue Growth And Expanding Profit Margins” published on November 19, 2013, published: “MusclePharm Corp.” on April 14, 2011. More interesting news about MusclePharm Corporation (OTCMKTS:MSLP) were released by: and their article: “MusclePharm Corporation Announces More Than $45 Million in Future Commitments …” published on May 26, 2016 as well as‘s news article titled: “MusclePharm: We’ve Been Here Before” with publication date: September 24, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.